US
China is stepping in to offer its homegrown jabs to poorer countries unlike wealthy countries
Company says its coronavirus vaccine reached critical milestones in clinical trials in Asia and Latin America
90% participants who took different doses of CoronaVac experienced significant increase in antibody levels